FN1 and cancer: Here, we have demonstrated for the first time, to our knowledge, that bepristat 2a prevented the adhesion of MCF-7 and MDA-MB-231 cells to collagen, fibronectin and endothelium, and impaired cancer cell transendothelial migration.